Climb Bio, Inc.

NASDAQ:CLYM

Biotechnology

Healthcare
$9.30 +0.17%

+$0.02 today

Market cap
$546.27M
Beta
0.10
P/E (TTM)
-14.7
EPS (TTM)
-$0.77
52W Low $1.17High $12.48

Volume 0.87M

Average 0.88M

Balance Sheet

Inspect the capital base behind the business.

Assets

$167.74M

FY 2025 · Annual

-22.8% YoY

Liabilities

$7.27M

FY 2025 · Annual

+37.0% YoY

Equity

$160.47M

FY 2025 · Annual

-24.3% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents46.92M43.59M93.11M87.23M35.69M
Short-term Investments89.56M79.98M13.69M63.69M65.39M
Net Receivables6.52M6.49M2.46M1.12M0
Inventory00000
Other Current Assets852K3.01M112K256K4.77M
Total Current Assets148.25M134.39M110.26M154.87M105.85M
Property, Plant & Equipment (Net)0471K199K490K793K
Goodwill00000
Intangible Assets00000
Long-term Investments24.92M0061.61M59.57M
Tax Assets00000
Other Non-current Assets70K128K15K215K1.53M
Total Non-current Assets24.99M599K214K62.32M61.89M
Total Assets173.24M134.99M110.47M217.19M167.74M
Account Payables1.4M750K66K705K2.27M
Short-term Debt0000256K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities00138K31K2.57M
Total Current Liabilities6.03M6.1M2.83M4.93M6.98M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities7K022K00
Total Non-current Liabilities7K180K37K375K285K
Total Liabilities6.04M6.28M2.87M5.31M7.27M
Common Stock3K3K3K7K5K
Retained Earnings(75.62M)(120.86M)(155.98M)(229.88M)(289.73M)
Accumulated OCI(123K)(358K)(2K)23K435K
Other Stockholders Equity00000
Minority Interest00000
Total Equity167.2M128.72M107.6M211.88M160.48M
Total Debt0480K349K532K541K
Net Debt(46.92M)(43.11M)(92.76M)(86.7M)(35.14M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$8.4M
Short-term Investments$101.2M
Other Current$3.8M
Total Current Assets$113.4M
PP&E (Net)$697.0K
Long-term Investments$36.7M
Other Non-current$1.5M
Total Non-current Assets$39.0M
Total Assets$152.4M

Analysis

Selected assets total $152.4M for Latest. The largest visible component is Short-term Investments at $101.2M, about 66.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13D/ASC 13D/A filingNov 9, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
S-3ASRS-3ASR filingNov 5, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026

How much cash does CLYM have?

Climb Bio, Inc. (CLYM) reported $35.69M in cash and equivalents in fiscal 2025.

How much debt does CLYM carry?

Climb Bio, Inc. (CLYM) reported $541,000.00 of total debt, with net debt of -$35.14M.